Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-14
DOI
10.3389/fendo.2021.531904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey
- (2019) Qiang Zeng et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis
- (2019) Yanan An et al. FASEB JOURNAL
- Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus
- (2019) Masahiro Yamamoto et al. PLoS One
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Screening for Osteoporosis to Prevent Fractures
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry
- (2018) William D Leslie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical implications of bone marrow adiposity
- (2018) A. G. Veldhuis-Vlug et al. JOURNAL OF INTERNAL MEDICINE
- Diagnosis and management of bone fragility in diabetes: an emerging challenge
- (2018) S.L. Ferrari et al. OSTEOPOROSIS INTERNATIONAL
- Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia
- (2017) Mikkel B Christensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies
- (2017) Mohammad Adil et al. Pharmacological Reports
- Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice
- (2016) MIN WU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort
- (2016) Sumit R. Majumdar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoporosis screening in postmenopausal women aged 50–64 years: BMI alone compared with current screening tools
- (2016) Xuezhi Jiang et al. MATURITAS
- Mechanisms of diabetes mellitus-induced bone fragility
- (2016) Nicola Napoli et al. Nature Reviews Endocrinology
- Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008–2011 Korea National Health and Nutrition Examination Survey
- (2016) Y. Lim et al. OSTEOPOROSIS INTERNATIONAL
- Diabetes and Obesity as Independent Risk Factors for Osteoporosis: Updated Results from the ROIS/EMEROS Registry in a Population of Five Thousand Post-Menopausal Women Living in a Region Characterized by Heavy Environmental Pressure
- (2016) Cosimo Neglia et al. International Journal of Environmental Research and Public Health
- Complications of Diabetes 2016
- (2016) Konstantinos Papatheodorou et al. Journal of Diabetes Research
- MR-Based Assessment of Bone Marrow Fat in Osteoporosis, Diabetes, and Obesity
- (2016) Christian Cordes et al. Frontiers in Endocrinology
- Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells
- (2015) Ken-ichiro Tanaka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care
- (2015) Wolfgang Rathmann et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-β Expression and Secretion
- (2014) Masakazu Notsu et al. ENDOCRINOLOGY
- The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
- (2014) Nicole C Wright et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increasing Adiposity Is Associated With Higher Adipokine Levels and Lower Bone Mineral Density in Obese Older Adults
- (2014) Lina Aguirre et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control
- (2014) T. Neumann et al. OSTEOPOROSIS INTERNATIONAL
- Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis
- (2012) Kyoko Okazaki et al. CALCIFIED TISSUE INTERNATIONAL
- Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes
- (2012) S. S. Johnston et al. DIABETES OBESITY & METABOLISM
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
- (2011) Ann V. Schwartz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The diagnosis of osteoporosis
- (2010) John A. Kanis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relation between Obesity and Bone Mineral Density and Vertebral Fractures in Korean Postmenopausal Women
- (2010) Kyong-Chol Kim et al. YONSEI MEDICAL JOURNAL
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started